Maze Therapeutics names Paula Johnson, Sophie Kornowski to board of directors
MAZE•Maze Therapeutics adds two directors
Maze Therapeutics named Paula Johnson and Sophie Kornowski to its board of directors.
Johnson is president of Wellesley College; she previously led the Connors Center at Brigham and Women’s Hospital.
Kornowski was CEO of Boston Pharmaceuticals from 2022; she previously led partnering at Roche and served on Chugai’s board.
